Covidien has built a portfolio defined by breadth and scale. Their IP spans the full range of technology domains in robotic surgery, with a large volume of active patents maintained and current. The portfolio’s strength rests on cumulative depth: total coverage across the field sustained through continued filing. Research investment continues relative to their business scale, and every patent is kept active and operational.
What is GreyB Spotlight?
GreyB Spotlight recognizes the top 1% innovators. Patent intelligence trusted by 70% of the Fortune 500. We evaluate Emerging Innovator status and Portfolio Strength. Awards are issued only after research surfaces qualifying signals. No applications. No quotas. No nominations.
